Agenus (NASDAQ: AGEN) shares declined 15.12% to $3.65 after the company reported that GlaxoSmithKline's (NYSE: GSK) MAGRITi study did not meet its first or second co-primary endpoint.
Cinedigm (NASDAQ: CIDM) slipped 14.87% to $2.69 after the company announced a proposed public offering of common stock.
Walter Energy (NYSE: WLT) shares tumbled 12.98% to $7.91 after the company priced $200 million of 9.5% Senior Secured Notes and $350 million of Senior Secured Second Lien PIK Toggle Notes.
The ExOne Company (NASDAQ: XONE) shares dropped 10.47% to $39.17 after the company reported downbeat Q4 results and issued a weak FY14 revenue outlook.
Clifton Bancorp (NASDAQ: CSBK) shares dropped 10.32% to $11.65 after the company announced stock offering results.
Response Genetics (NASDAQ: RGDX) slipped 9.47% to $1.34 after the company reported Q4 results. The company posted a quarterly net loss of $3.2 million, or $0.09 per share, versus a year-ago net loss of $0.5 million, or $0.01 per share.
Guess? (NYSE: GES) shares fell 5.18% to $27.27 after the company issued downbeat outlook. The retailer projected to post a Q1 loss of $0.05 to $0.09 per share.
FuelCell Energy (NASDAQ: FCEL) tumbled 4.99% to $2.51 after falling 4.00% on Wednesday.
Posted-In: market losersNews Movers & Shakers Intraday Update Markets
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Most Popular Are Massive Xbox One 'Titanfall' Sales To Blame For Xbox 360 Game Delay? Warren Buffett's Conflicting Bitcoin Views Marijuana Economy Has Plenty Of Room To Grow Fox On Stocks' 17-Year-Old Rachel Fox Teaches A New Generation How To Trade Mid-Morning Market Update: Markets Edge Higher; FedEx Profit Misses Estimates Five Star Stock Watch: Herbalife Related Articles (AGEN + CIDM) Morning Market Losers US Stock Futures Drop Ahead Of Jobless Claims Report Agenus Therapeutics Reports GlaxoSmithKline's Magrit Study Does Not Meet First or Second Primary Endpoint Earnings Estimates Moving Higher for Agenus (AGEN): Time to Buy? - Tale of the Tape UPDATE: H.C. Wainwright & Co. Initiates Coverage on Agenus Following 4-Antibody Acquisition Agenus Announces Public Offering of Common Stock Around the Web, We're Loving... Check Out the New iPad 4
No comments:
Post a Comment